The Journal of Heart and Lung Transplantation
Volume 29, Issue 5 , Pages 504-508 , May 2010

Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes

  • Jon A. Kobashigawa, MD

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • Corresponding Author InformationReprint requests: Jon A. Kobashigawa, MD, Cedars-Sinai Heart Institute, 8700 Beverly Boulevard, Los Angeles, CA 90048. Telephone: 310-248-8300. Fax: 310-248-8333
    • ,
  • Krista K. Kiyosaki, BA

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Jignesh K. Patel, MD, PhD

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Michelle M. Kittleson, MD, PhD

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Bernard M. Kubak, MD

      Affiliations

    • Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Stephanie N. Davis, BS

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Matt A. Kawano, BS

      Affiliations

    • Division of Cedars-Sinai Heart Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California
    • ,
  • Abbas A. Ardehali, MD

      Affiliations

    • Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

References 

  1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report—2007. J Heart Lung Transplant. 2007;26:769–781
  2. Jusko WJ, Thomson AW, Fung J, et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit. 1995;17:606–614
  3. Kowalski R, Post D, Schneider MC, et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003;17:77–88
  4. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82:663–668
  5. Rodrigo E, Arias M. A practical approach to immune monitoring in kidney transplantation. Minerva Urol Nefrol. 2007;59:337–352
  6. Cadillo-Chavez R, Echegaray S, Santiago-Delpin EA, et al. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc. 2006;38:918–920
  7. Thai NL, Blisard D, Tom K, et al. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: correlation between low T-cell responses and infection. Transplantation. 2006;82:1649–1652
  8. Zeevi A, Britz JA, Bentlejewski CA, et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transplant Immunol. 2005;15:17–24
  9. Gupta S, Mitchell JD, Markham DW, et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant. 2008;27:817–822
  10. Lee TC, Goss JA, Rooney CM, et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant. 2006;20:689–694

PII: S1053-2498(09)01536-8

doi: 10.1016/j.healun.2009.12.015

The Journal of Heart and Lung Transplantation
Volume 29, Issue 5 , Pages 504-508 , May 2010

Article Tools

* Image Usage & Resolution